NR
NRC.US NRC Health
- Market cap
- USD 559M
- P/E
- 97.5x
- P/B
- 73.46x
- ROE
- -
- Dividend yield
- 1.96%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NRC.US undervalued?
Graham numberThe Graham number of NRC Health cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NRC Health fundamental analysis
No fundamental analysis for NRC Health yet.
NRC Health stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NRC Health
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experie…
Full company profileNRC Health financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
NRC Health annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 109M | 118M | 120M | 128M | 133M | 148M | 152M | 149M | 143M | 137M | 145M |
| Gross Profit | 63.8M | 68.5M | 72.1M | 81.5M | 84.1M | 95.6M | 94.5M | 92.6M | 86.1M | 77.4M | 66.3M |
| Operating Income | 31.2M | 34.2M | 35.3M | 43.0M | 42.7M | 50.3M | 46.5M | 40.0M | 35.2M | 22.6M | 15.0M |
| EBITDA | 35.8M | 39.0M | 41.7M | 48.6M | 50.8M | 56.7M | 49.3M | 46.0M | 41.3M | 30.2M | 23.6M |
| Net Income | 20.5M | 22.9M | 30.0M | 32.4M | 37.3M | 37.5M | 31.8M | 31.0M | 24.8M | 11.6M | 6.19M |
| EPS | 0.83 | 0.91 | 1.07 | 1.26 | 1.45 | 1.46 | 1.27 | 1.26 | 1.04 | 0.52 | 0.28 |
| Balance Sheet | |||||||||||
| Total Assets | 121M | 127M | 108M | 111M | 133M | 158M | 130M | 122M | 133M | 135M | 139M |
| Total Liabilities | 37.8M | 37.3M | 88.6M | 77.8M | 69.1M | 72.2M | 58.4M | 73.5M | 101M | 121M | 148M |
| Shareholders' Equity | 82.8M | 90.0M | 19.1M | 32.9M | 64.3M | 85.3M | 72.0M | 49.0M | 31.3M | 14.0M | -9.12M |
| Cash & Short-term Investments | 33.0M | 34.7M | 13.0M | 13.5M | 34.7M | 54.4M | 25.0M | 6.65M | 4.23M | 4.14M | 3.63M |
| Total Debt | 3.54M | 1.07M | 37.8M | 34.7M | 33.2M | 28.7M | 23.4M | 39.0M | 64.4M | 79.0M | 103M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 26.8M | 28.1M | 39.8M | 40.9M | 40.6M | 46.3M | 36.3M | 38.1M | 34.6M | 26.5M | 22.1M |
| Capital Expenditure | 3.97M | 4.82M | 5.97M | 4.66M | 3.98M | 5.51M | 9.84M | 15.8M | 15.4M | 10.7M | 5.59M |
| Free Cash Flow | 22.9M | 23.3M | 33.9M | 36.3M | 36.7M | 40.8M | 26.4M | 22.3M | 19.2M | 15.7M | 16.5M |
| Ratios | |||||||||||
| ROE | 24.8% | 25.5% | 157.5% | 98.5% | 57.9% | 43.9% | 44.1% | 63.3% | 79.2% | 82.9% | - |
| ROA | 17.0% | 18.0% | 27.9% | 29.3% | 27.9% | 23.8% | 24.4% | 25.3% | 18.7% | 8.6% | 4.4% |
| Net Profit Margin | 18.8% | 19.5% | 25.1% | 25.3% | 28.0% | 25.3% | 21.0% | 20.8% | 17.3% | 8.4% | 4.3% |
| Debt to Equity | 0.04x | 0.01x | 1.98x | 1.06x | 0.52x | 0.34x | 0.32x | 0.80x | 2.06x | 5.65x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
NRC Health dividends
- Dividend yield
- 1.96%
- Forward dividend
- 0.64 USD
- Payout ratio
- 94.6%
- Ex-dividend date
- Dec 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 11.0M | 0.49 | 94.6% |
| 2024 | USD 11.5M | 0.48 | 46.2% |
| 2023 | USD 36.4M | 1.47 | 117.4% |
| 2022 | USD 21.0M | 0.84 | 65.9% |
| 2021 | USD 9.16M | 0.36 | 24.4% |
| 2020 | USD 10.5M | 0.41 | 28.2% |
| 2019 | USD 31.3M | 1.22 | 96.6% |
| 2018 | USD 16.9M | 0.60 | 56.1% |
| 2017 | USD 16.9M | 0.67 | 73.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns NRC Health
- Insiders 51.33%
- Institutions 48.67%
- Public & others 0.00%
- Shares outstanding 21.2M
- Free float 11.1M
Top funds holding NRC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Virtus KAR Small-Cap Growth I | 923K | 4.35% | -45.97% | Jun 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 498K | 2.35% | 0.00% | Sep 2026 |
| Virtus GF US Small Cap Focus I USD Acc | 306K | 1.44% | -1.42% | Sep 2026 |
| iShares Russell 2000 ETF | 301K | 1.42% | 0.00% | Oct 2026 |
| Heartland Value Investor | 300K | 1.41% | 0.00% | Oct 2026 |
| IA Clarington QV Canadian Small Cap A | 188K | 0.88% | 0.00% | Sep 2026 |
| Fidelity Small Cap Index | 130K | 0.61% | 0.00% | Aug 2026 |
| WisdomTree US SmallCap Dividend ETF | 126K | 0.59% | 0.00% | Oct 2026 |
| DFA US Micro Cap I | 120K | 0.56% | 0.00% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 112K | 0.53% | -0.38% | Oct 2026 |
| Fidelity Small-Mid Multifactor ETF | 109K | 0.51% | 0.00% | Oct 2026 |
| NEI Canadian Small Cap Equity RS A | 102K | 0.48% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap I | 97.1K | 0.46% | -3.46% | Sep 2026 |
| JNL Multi-Manager Small Cap Growth A | 87.5K | 0.41% | -10.71% | Sep 2026 |
| Column Small Cap | 85.2K | 0.40% | +8.73% | Sep 2026 |
| Vanguard Russell 2000 ETF | 68.9K | 0.32% | +1.66% | Sep 2026 |
| iShares U.S. Small-Cap Eq Fac ETF | 67.9K | 0.32% | 0.00% | Oct 2026 |
| Dimensional US Small Cap ETF | 65.6K | 0.31% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 63.6K | 0.30% | +0.20% | Oct 2026 |
| Virtus KAR Small-Cap Growth A | 56.6K | 0.27% | +77.02% | Jun 2026 |
Top institutions holding NRC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 2.03M | 9.57% | -22.98% | Jun 2026 |
| BlackRock Inc | 1.06M | 5.00% | +8.76% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 859K | 4.05% | -14.23% | Jun 2026 |
| Vanguard Capital Management, LLC | 667K | 3.14% | +0.56% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 492K | 2.32% | +0.09% | Sep 2026 |
| Willis Investment Counsel | 435K | 2.05% | +93.55% | Jun 2026 |
| Geode Capital Management, LLC | 420K | 1.98% | +6.65% | Jun 2026 |
| QV Investors Inc | 373K | 1.76% | -2.31% | Jun 2026 |
| Farmenrs & Merchants Investments Inc | 331K | 1.56% | +330,549.00% | Jun 2026 |
| Renaissance Technologies Corp | 314K | 1.48% | -3.63% | Sep 2026 |
| Heartland Advisors Inc | 300K | 1.41% | 0.00% | Sep 2026 |
| State Street Corp | 298K | 1.41% | -0.79% | Jun 2026 |
| Bank of New York Mellon Corp | 252K | 1.19% | +0.61% | Jun 2026 |
| Northern Trust Corp | 238K | 1.12% | -6.79% | Jun 2026 |
| Hotchkis & Wiley Capital Management LLC | 188K | 0.89% | -34.49% | Jun 2026 |
| Wells Fargo & Co | 180K | 0.85% | +53.66% | Jun 2026 |
| AQR Capital Management LLC | 122K | 0.58% | -28.89% | Jun 2026 |
| Charles Schwab Investment Management Inc | 113K | 0.53% | +0.83% | Jun 2026 |
| Northwest & Ethical Investments L.P. | 102K | 0.48% | -20.77% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 97.2K | 0.46% | +4.34% | Jun 2026 |
NRC Health company profile
- Company name
- NRC Health
- Ticker
- NRC.US
- Exchange
- USA Stocks
- Listed since
- Oct 10, 1997
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 357
- Fiscal year end
- December
- Address
- 1245 Q Street, Lincoln, NE, United States, 68508
- Phone
- 402 475 2525
- Website
- nrchealth.com
About NRC Health
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.
NRC Health management
8- Mr. Michael D. HaysFounder & Chairman · born 1955
- Mr. Trent S. GreenInterim Principal Financial Officer, CEO, Principal Executive Officer & Director · born 1972
- Ms. Helen L. HrdyEVP & COO · born 1965
- Mr. Andrew MonnichEVP & Chief Corporate Development Officer · born 1976
- Mr. Jason R. RauExecutive Vice President of Sales · born 1971
- Ms. Jordan N. FreemanChief Accounting Officer · born 1988
- Ms. Jennifer BaronChief Experience Officer
- Mr. David BurikExecutive Vice President of Strategic Insights · born 1958